Clearpoint Income Tax Expense from 2010 to 2025

CLPT Stock  USD 14.53  0.32  2.25%   
Clearpoint Neuro Income Tax Expense yearly trend continues to be comparatively stable with very little volatility. Income Tax Expense is likely to outpace its year average in 2025. From the period from 2010 to 2025, Clearpoint Neuro Income Tax Expense quarterly data regression had r-value of (0.61) and coefficient of variation of (605.85). View All Fundamentals
 
Income Tax Expense  
First Reported
2011-06-30
Previous Quarter
721 K
Current Value
430.7 K
Quarterly Volatility
522.7 K
 
Yuan Drop
 
Covid
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 330 K or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 17.19. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Latest Clearpoint Neuro's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of Clearpoint Neuro over the last few years. It is Clearpoint Neuro's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
964.2K2.3M910.0K103.0K1.3M-18.9M-18.0M100%
       Timeline  

Clearpoint Income Tax Expense Regression Statistics

Arithmetic Mean(1,122,829)
Geometric Mean1,389,498
Coefficient Of Variation(605.85)
Mean Deviation4,329,580
Median1,276,140
Standard Deviation6,802,641
Sample Variance46.3T
Range21.4M
R-Value(0.61)
Mean Square Error30.9T
R-Squared0.38
Significance0.01
Slope(877,850)
Total Sum of Squares694.1T

Clearpoint Income Tax Expense History

2025-18 M
2024-18.9 M
20231.3 M
2022103 K
2021910 K
20202.3 M
2019964.2 K

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as Income Tax Expense, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Income Tax Expense-18.9 M-18 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.

Trending Assets

TELA
Tela Bio
2.52  -0.08  -3.08 
SWAV
Shockwave Medical
0.00  0.00  0.00 
LUNG
Pulmonx Corp
8.62  -0.6  -6.51 
NPCE
Neuropace
13.48  -0.36  -2.6 
RCEL
Avita Medical
8.90  -0.72  -7.48 
OSA
ProSomnus, Common Stock
0.00  0.00  0.00 
INGN
Inogen Inc
7.95  -0.16  -1.97 
TBIO
Telesis Bio
0.00  0.00  0.00 
INSP
Inspire Medical Systems
184.02  -12.59  -6.4 
NARI
Inari Medical
79.97  0.00  0.00 
OM
Outset Medical
0.73  -0.03  -3.95 
TMCI
Treace Medical Concepts
9.13  -0.57  -5.88 
CTSO
Cytosorbents Crp
1.07  -0.03  -2.73 
KIDS
Orthopediatrics Corp
23.00  0.05  0.22 
ELMD
Electromed
26.83  -0.63  -2.29 
SRDX
SurModics
35.90  0.36  1.01 
LIVN
LivaNova PLC
41.45  -0.25  -0.6 
SGHT
Sight Sciences
2.64  -0.17  -6.05 
APYX
Apyx Medical
1.38  -0.05  -3.5 
News Freq…Investor S…